London-based Tate & Lyle PLC, global provider of specialty food ingredients and solutions, has acquired Biovelop, a Swedish manufacturer of oat beta glucan.
 
Operating from a production facility in Kimstad, Sweden, Biovelop produces oat beta glucan under the brand name PromOat for use in the food, beverage and supplement markets, and under the brand name Avenacare for use in the cosmetics industry. In addition, it produces a range of other oat-based ingredients including PrOATein (oat protein), oat dextrin and insoluble oat fiber. Biovelop’s products are manufactured from non-GMO oats sourced from within Sweden using a chemical-free process.
 
Beta glucan is a soluble fiber that has widely approved health claims, including EFSA, for lowering cholesterol and reducing postprandial glycaemic response.
Biovelop is a relatively early-stage business having been founded in 2005 and made its first sale of commercial product in 2010.
 
Olivier Rigaud, president, Speciality Food Ingredients for Tate & Lyle said, “We are delighted to welcome the Biovelop business and its employees to Tate & Lyle. The addition of Biovelop’s soluble oat beta glucan, supported by strong scientific health claims, represents an excellent addition to Tate & Lyle’s existing fibers and health and wellness portfolios.”